Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Sezary Syndrome 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Hepatitis 1 Colitis 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

mogamulizumab 4 Specimen Handling 3 Immunoglobulin G 3 Disulfides 3 Cyclophosphamide 3 Biopsy 3 pembrolizumab 2 fludarabine phosphate 2 fludarabine 2 Whole-Body Irradiation 2 Tacrolimus 2 Photopheresis 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 Mycophenolic Acid 2 Magnetic Resonance Spectroscopy 2 Busulfan 2 Blood Specimen Collection 2 talimogene laherparepvec 1 magrolimab 1 duvelisib 1 durvalumab 1 Vincristine 1 Valganciclovir 1 Urine Specimen Collection 1 Transplantation 1 Therapeutics 1 Sirolimus 1 Radiotherapy 1 Prednisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sezary Syndrome × Methoxsalen × 1 year × Clear all

NCT05157581 2025-12-30

ECP

University of Pittsburgh

Sezary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡